Hematopoietic stimulation by amifostine and sodium phenylbutyrate: what is the potential in MDS?
List
A F
AF
The Arizona Cancer Center and University of Arizona College of Medicine, Tucson 85718-0524, USA.
D004999:Amifostine / Q000009:adverse effects / Q000627:therapeutic use*; D002454:Cell Differentiation / Q000187:drug effects; D002986:Clinical Trials as Topic; D019610:Cytoprotection / Q000187:drug effects*; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D010654:Phenylbutyrates / Q000627:therapeutic use*; D011355:Prodrugs / Q000009:adverse effects / Q000627:therapeutic use*
D010654:Phenylbutyrates; D011355:Prodrugs; C075773:4-phenylbutyric acid; D004999:Amifostine